아기오스제약(주)
US ˙ NasdaqGS ˙ US00847X1046

SecurityAGIO / Agios Pharmaceuticals, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership132,540 shares
Latest Disclosed Value $ 4,483,828
UBS Group AG ownership in AGIO / Agios Pharmaceuticals, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 132,540 shares of Agios Pharmaceuticals, Inc. (US:AGIO) valued at $4,483,828 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 126,665 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of 4.64% during the quarter. The current value of the position is $3,815,827 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (AGIO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AGIO / Agios Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 132,540 5,875 4.64 4,484 30.06 0.0001
2026-01-29 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 126,665 -116,148 -47.83 3,448 -64.63 0.0006
2025-11-13 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 242,813 123,979 104.33 9,747 146.61 0.0015
2025-08-14 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 118,834 -12,808 -9.73 3,952 2.46 0.0007
2025-05-13 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 131,642 -102,701 -43.83 3,857 -49.91 0.0007
2025-02-14 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 234,343 120,157 105.23 7,701 51.78 0.0014
2024-11-14 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 114,186 44,827 64.63 5,073 69.67 0.0011
2024-08-14 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 69,359 -101,526 -59.41 2,991 -40.15 0.0007
2024-05-13 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 170,885 169,031 9,117.10 4,997 12,085.37 0.0012
2024-02-09 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 1,854 -58,539 -96.93 41 -97.26 0.0000
2023-11-09 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 60,393 -11,905 -16.47 1,495 -27.02 0.0005
2023-08-11 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 72,298 -13,537 -15.77 2,047 3.86 0.0007
2023-05-12 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 85,835 -6,250 -6.79 1,972 -23.75 0.0007
2023-02-08 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 92,085 77,425 528.14 2,586 522.89 0.0010
2022-11-10 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 14,660 -64,475 -81.47 415 -76.35 0.0002
2022-08-10 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 79,135 33,272 72.55 1,755 31.36 0.0007
2022-05-16 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 45,863 -139,562 -75.27 1,336 -78.08 0.0004
2022-02-14 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 185,425 91,504 97.43 6,095 40.60 0.0017
2021-11-15 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 93,921 81,455 653.42 4,335 531.00 0.0014
2021-08-13 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 12,466 -13,871 -52.67 687 -49.49 0.0002
2021-05-12 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 26,337 25,132 2,085.64 1,360 2,515.38 0.0005
2021-02-11 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 1,205 995 473.81 52 642.86 0.0000
2020-11-12 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 210 -2,597 -92.52 7 -95.33 0.0000
2020-07-31 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 2,807 -735 -20.75 150 19.05 0.0001
2020-05-01 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 3,542 1,413 66.37 126 23.53 0.0001
2020-02-14 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 2,129 -54,309 -96.23 102 -94.42 0.0000
2019-11-14 2019-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 56,438 50,819 904.41 1,829 553.21 0.0007
2019-08-14 2019-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,619 1,020 22.18 280 -9.68 0.0001
2019-05-14 2019-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 4,599 -56,671 -92.49 310 -89.03 0.0001
2019-02-14 2018-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 61,270 36,387 146.23 2,825 47.21 0.0013
2018-11-14 2018-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 24,883 17,204 224.04 1,919 196.60 0.0008
2018-08-14 2018-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 7,679 -79,963 -91.24 647 -90.97 0.0003
2018-05-15 2018-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 87,642 58,486 200.60 7,167 329.93 0.0031
2018-02-14 2017-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 29,156 -20,101 -40.81 1,667 -49.30 0.0007
2017-11-14 2017-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 49,257 10,830 28.18 3,288 66.31 0.0015
2017-11-14 2017-06-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 38,427 34,112 790.54 1,977 684.52 0.0010
2017-08-14 2017-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 38,427 34,112 1,977
2017-11-14 2017-03-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 4,315 -55,363 -92.77 252 -89.88 0.0001
2017-05-12 2017-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 4,315 -55,363 252
2017-02-14 2016-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 59,678 24,455 69.43 2,491 33.85 0.0014
2016-11-14 2016-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 35,223 -4,227 -10.71 1,861 12.65 0.0011
2016-08-12 2016-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 39,450 34,165 646.45 1,652 671.96 0.0010
2016-05-12 2016-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 5,285 -73,755 -93.31 214 -95.83 0.0001
2016-02-16 2015-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 79,040 73,432 1,309.42 5,131 1,195.71 0.0033
2015-11-13 2015-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,608 -18 -0.32 396 -36.64 0.0003
2015-08-14 2015-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,626 -673 -10.68 625 5.22 0.0004
2015-05-14 2015-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 6,299 -142,165 -95.76 594 -96.43 0.0004
2015-02-17 2014-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 148,464 148,464 16,634 0.0116
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-07-31 2020-06-30 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-01 2020-03-31 13F AGIOS PHARMACEUTICALS COM Call 50,000 0.00 1,774 -25.71 n/a n/a n/a
2020-02-14 2019-12-31 13F AGIOS PHARMACEUTICALS COM Call 50,000 2,388 n/a n/a n/a
2017-11-14 2017-06-30 13F/A AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-03-31 13F/A AGIOS PHARMACEUTICALS COM Call 28,200 1,647 n/a n/a n/a
2017-05-12 2017-03-31 13F AGIOS PHARMACEUTICALS COM Call 28,200 1,647 n/a n/a n/a
2016-08-12 2016-06-30 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-12 2016-03-31 13F AGIOS PHARMACEUTICALS COM Call 65,000 2,639 n/a n/a n/a
2015-11-13 2015-09-30 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F AGIOS PHARMACEUTICALS COM Call 100 -75.00 11 -71.05 n/a n/a n/a
2015-05-14 2015-03-31 13F AGIOS PHARMACEUTICALS COM Call 400 -20.00 38 -32.14 n/a n/a n/a
2015-02-17 2014-12-31 13F AGIOS PHARMACEUTICALS COM Call 500 56 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-12 2021-03-31 13F AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F AGIOS PHARMACEUTICALS COM Put 12,500 0.00 542 23.74 n/a n/a n/a
2020-11-12 2020-09-30 13F AGIOS PHARMACEUTICALS COM Put 12,500 438 n/a n/a n/a
2020-07-31 2020-06-30 13F AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-01 2020-03-31 13F AGIOS PHARMACEUTICALS COM Put 9,300 330 n/a n/a n/a
2015-05-14 2015-03-31 13F AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F AGIOS PHARMACEUTICALS COM Put 1,400 157 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.